Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (211-220 of 280) with videos related to

Pageof 28
Sort By:
Infectious Agents and Cancer|June 25, 2016
Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in ItalyMartina Taborelli, Jerry Polesel, Maurizio Montella, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Leukemia Research|July 30, 2015
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6KDanijela Maksimovic-Ivanic, Marija Mojic, Mirna Bulatovic, et al.
The British Journal of Nutrition|October 10, 2017
Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control studyLivia S A Augustin, Martina Taborelli, Maurizio Montella, et al.
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Cells|October 17, 2019
Translational Application of Circulating DNA in Oncology: Review of the Last Decades AchievementsNatalia O Tuaeva, Luca Falzone, Yuri B Porozov, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
International Journal of Molecular Sciences|September 28, 2024
Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic HyperplasiaMichele Stella, Giorgio Ivan Russo, Rosario Leonardi, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Pageof 28

Showing results (211-220 of 280) with videos related to

Sort By:
Pageof 28
Infectious Agents and Cancer|June 25, 2016
Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in ItalyMartina Taborelli, Jerry Polesel, Maurizio Montella, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Leukemia Research|July 30, 2015
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6KDanijela Maksimovic-Ivanic, Marija Mojic, Mirna Bulatovic, et al.
The British Journal of Nutrition|October 10, 2017
Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control studyLivia S A Augustin, Martina Taborelli, Maurizio Montella, et al.
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Cells|October 17, 2019
Translational Application of Circulating DNA in Oncology: Review of the Last Decades AchievementsNatalia O Tuaeva, Luca Falzone, Yuri B Porozov, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
International Journal of Molecular Sciences|September 28, 2024
Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic HyperplasiaMichele Stella, Giorgio Ivan Russo, Rosario Leonardi, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Pageof 28